Management of Renal Dysfunction in Patients Receiving a Liver Transplant

被引:6
作者
Lau, Christine [1 ]
Martin, Paul [2 ]
Bunnapradist, Suphamai [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Kidney & Pancreas Transplant Program, Div Nephrol,Dept Med, Los Angeles, CA 90024 USA
[2] Univ Miami, Div Hepatol, Dept Med, Miami, FL 33136 USA
关键词
Renal failure; Liver-kidney transplant; Liver transplant; CONTRAST-INDUCED NEPHROPATHY; STANDARD-DOSE TACROLIMUS; CHRONIC KIDNEY-DISEASE; MYCOPHENOLATE-MOFETIL; RISK-FACTORS; THROMBOTIC MICROANGIOPATHY; CALCINEURIN INHIBITOR; HEPATORENAL-SYNDROME; N-ACETYLCYSTEINE; CYSTATIN-C;
D O I
10.1016/j.cld.2011.08.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Renal dysfunction is a frequent complication in patients with endstage liver disease awaiting orthotopic liver transplantation. Although the stereotypical form of renal dysfunction is the hepatorenal syndrome, common causes of acute kidney injury include prerenal azotemia and acute tubular necrosis in this population. Management involves hemodynamic support, renal replacement therapy, and mitigation of risk factors. Renal dysfunction in a cirrhotic patient usually implies a poor prognosis in the absence of liver transplantation. An important issue is the frequent need for kidney, in addition to liver, transplantation if renal insufficiency has been persistent in a decompensated cirrhotic.
引用
收藏
页码:807 / +
页数:15
相关论文
共 60 条
  • [1] Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease:: A meta-analysis of randomized, controlled trials
    Alonso, A
    Lau, J
    Jaber, BL
    Weintraub, A
    Sarnak, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) : 1 - 9
  • [2] Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN
    Alric, L
    Plaisier, E
    Théault, S
    Péron, JM
    Rostaing, L
    Pourrat, J
    Ronco, P
    Piette, JC
    Cacoub, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : 617 - 623
  • [3] AMORE A, 1994, LAB INVEST, V70, P68
  • [4] Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
    Angeli, P
    Volpin, R
    Gerunda, G
    Craighero, R
    Rone, P
    Merenda, R
    Amodio, P
    Sticca, A
    Caregaro, L
    Maffei-Faccioli, A
    Gatta, A
    [J]. HEPATOLOGY, 1999, 29 (06) : 1690 - 1697
  • [5] Acute Kidney Injury Following Liver Transplantation: Definition and Outcome
    Barri, Yousri M.
    Sanchez, Edmund Q.
    Jennings, Linda W.
    Melton, Larry B.
    Hays, Steven
    Levy, Marlon F.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (05) : 475 - 483
  • [6] A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction
    Barton, T. D.
    Blumberg, E. A.
    Doyle, A.
    Ahya, V. N.
    Ferrenberg, J. M.
    Brozena, S. C.
    Limaye, A. P.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) : 102 - 107
  • [7] Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
    Batts, E. D.
    Lazarus, H. M.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 40 (08) : 709 - 719
  • [8] Hepatitis B virus-associated nephropathy
    Bhimma, R
    Coovadia, HM
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (02) : 198 - 211
  • [9] Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study
    Boudjema, K.
    Camus, C.
    Saliba, F.
    Calmus, Y.
    Salame, E.
    Pageaux, G.
    Ducerf, C.
    Duvoux, C.
    Mouchel, C.
    Renault, A.
    Compagnon, P.
    Lorho, R.
    Bellissant, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (05) : 965 - 976
  • [10] The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension
    Boyer, TD
    Haskal, ZJ
    [J]. HEPATOLOGY, 2005, 41 (02) : 386 - 400